Clinical Trial NCT03157635
Trial
Roche – BP39144 COMPOSER (NCT03157635)
Clinical trial ID
NCT03157635
Drug name
Crovalimab
Company:
Roche
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
1/2
Current status
Active, not recruiting
Start
11/2016
Substance
Monoclonal antibody
Research question
---
Delivery method of drug
i.v. / s.c.
Frequency
every 4 weeks
Clinical trial locations
France Germany Hungary Italy Japan Netherlands South Korea